Wegovy vs. Ozempic: What To Know
US$ 26.93
sglt2 inhibitors vs glp-1 agonists Effect of combination treatment with glucagon-like peptide-1 receptor and sodium-glucose cotransporter-2 on incidence of cardiovascular and serious renal events: population based cohort study SGLT-2 inhibitors and GLP-1 receptor
Description
Both are administered via weekly subcutaneous injections, but their licensed indications differ
This article will help you unpack the idea and apply it to your own life and needs.
[19] Gejl, M., & Egefjord, L
doi: 10.1111/dom.13326 [DOI] [PubMed] [Google Scholar] 180.Elkeeb R, Eid T, Yu J, Nguyen H, Atef E
The Bottom Line Nausea from GLP-1 medications is common, but it doesnt have to derail your treatment
Thinking around obesity has shifted over the years
